Main Category: Conferences
Article Date: 15 May 2012 - 8:00 PDT
email to a friend  
printer friendly  
opinions  <!-- 
rate article Patient / Public:
Healthcare Prof: Strategies for navigating the regulatory, manufacturing, sales and marketing route to biosimilar market entry.
11 - 13 September 2012, Jumeirah Carlton Tower, London, UK
Get competitive insight into global regulatory strategies, and find out how to successfully bring biosimilars to-market in developed and developing regions. With leading companies from India, Israel, Switzerland, UK, USA, Germany and more speaking at the World Biosimilars Congress, this is a great opportunity to get a complete overview of the development pathway for biosimilars in your region of interest, and find out which other lucrative markets you should be targeting.
- Compare regulatory pathways for biosimilars in developed and developing markets
- Get critical insight on to-market models from Teva and Sandoz in the EU and US, and beyond
- Debate the minimum level of clinical testing required for a safe and approvable product
- Consider the best options for product selection based on market analysis and competitive landscape
- Find out how to design a patent-dispute pathway to avoid IP infringement
- Understand how to demonstrate biosimilarity with comparability to the reference product
- Ensure that immunogenicity standards are kept seamless from development to in-clinic
- Learn about new frontiers in cell line development and the opportunities for biosimilar manufacture
- Find out how to improve bioprocessing and production of biosimilars
- Network with regulators, drug manufacturers and service providers to assess and secure new partners
Download the brochure for more information.
To book your place contact: Marcia Ardila on email: marcia.ardila@terrapinn.com or register your place online at http://www.terrapinn.com/2012/biosimilars-congress
- Additional
- References
- Citations
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'World Biosimilars Congress 2012, 11-13 September, London, UK'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
back to top | home | privacy policy
MediLexicon International LtdBexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Tidak ada komentar:
Posting Komentar